Vault-13

GALAPAGOS NV NPV ISIN BE0003818359 SEDOL B07Q2V5 GLPGF

COMMONSTOCK · Common Stock · CUSIP B44170106

Belgian pharmaceutical company

1 institutional holders
673,508673.5k shares reported held*
1.0% of all shares outstanding*
$141.0mreported value*

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 64.7m as of 2019-12-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $209.35.

Insider purchases and sales in Q4 2019

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported in Q4 2019.

Holders, Q4 2019

#ManagerLocationShares Value% of their portfolioChangeShares change
1 GILDER GAGNON HOWE & CO LLC 1.46% of their portfolio New York, NY 673,508673.5k $141.0m $141.0m 1.46% —